Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.26, expectations were $1.17.

Vinod Khosla said he measures AI industry health by API calls, not stock prices or Wall Street trends. Debate over an AI ...

Nearly two decades after the Supreme Court affirmed the right to choose a life partner, honour killings continue with ...

In the past few months, the St. Paul Downtown Development Corporation has acquired the Alliance Bank Center, the Capital City ...

The application deadline for general scholarships is March 1, 2026. The deadline for nursing, allied health, and trade school ...

Thank you and welcome to our third quarter earnings call. Joining me today are Vince Calabrese, our Chief Financial Officer; ...